{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:05:51Z","timestamp":1794049551795,"version":"4.8.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cannabidiol (CBD) has emerged as a promising neuroprotective compound, with potential benefits for cognitive and emotional behaviors. However, the consistency of its effects across preclinical models remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of 123 animal studies assessing the impact of CBD on anxiety-like and depressive-like behaviors, as well as cognition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CBD consistently reduced anxiety- and depressive-like behaviors, with moderate effect sizes observed in paradigms such as the elevated plus maze, novelty suppressed feeding, forced swim, sucrose preference, and tail suspension test. Cognitive effects were more heterogeneous: CBD improved performance in adverse, discriminatory, and working memory tasks, while effects were small or inconsistent in hippocampus-dependent spatial memory tests. Subgroup analyses revealed that CBD\u2019s efficacy often depended on the type of behavioral test and the presence of underlying pathologies. Mechanistic evidence implicates serotonergic signaling (notably 5-HT1A receptors), endocannabinoid modulation, anti-inflammatory and neurotrophic pathways, as well as mitochondrial and synaptic plasticity processes, as contributors to these behavioral outcomes. Risk of bias assessment indicated moderate to high quality across studies, confirming the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our results indicate that CBD reduces anxiety-like and depressive-like behaviors and improves cognitive performance across a variety of preclinical models. While these findings support its therapeutic potential and provide a rationale for guiding translational research, clinical evidence in humans is still limited and inconclusive, underscoring the need for further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41380-026-03733-x","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:58:45Z","timestamp":1782802725000},"page":"6676-6692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of cannabidiol on anxiety- and depressive-like behaviors and cognition: a systematic review and meta-analysis of preclinical studies"],"prefix":"10.1038","volume":"31","author":[{"given":"Jeferson","family":"Jantsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Wickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel de Farias","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7203-3467","authenticated-orcid":false,"given":"Luciano St\u00fcrmer","family":"de Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Elena","family":"Dur\u00e1n-Carabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4456-767X","authenticated-orcid":false,"given":"Renata Padilha","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"3733_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","volume":"238","author":"SC Britch","year":"2021","unstructured":"Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238:9\u201328.","journal-title":"Psychopharmacology"},{"key":"3733_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-051921-083709","volume":"63","author":"R Mechoulam","year":"2023","unstructured":"Mechoulam R. A delightful trip along the pathway of cannabinoid and endocannabinoid chemistry and pharmacology. Annu Rev Pharmacol Toxicol. 2023;63:1\u201313.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3733_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","volume":"15","author":"R Mechoulam","year":"2014","unstructured":"Mechoulam R, Hanu\u0161 LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci. 2014;15:757\u201364.","journal-title":"Nat Rev Neurosci"},{"key":"3733_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","volume":"5","author":"SE O\u2019Sullivan","year":"2023","unstructured":"O\u2019Sullivan SE, Jensen SS, Nikolajsen GN, Bruun HZ, Bhuller R, Hoeng J. The therapeutic potential of purified cannabidiol. J Cannabis Res. 2023;5:21.","journal-title":"J Cannabis Res"},{"key":"3733_CR5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/ph18040446","volume":"18","author":"E Rafailovska","year":"2025","unstructured":"Rafailovska E, Xhemaili E, Naumovska Z, Gigopulu O, Miova B, Suturkova L, et al. Unlocking the antidiabetic potential of CBD: In vivo preclinical studies. Pharmaceuticals. 2025;18:446.","journal-title":"Pharmaceuticals"},{"key":"3733_CR6","volume":"68","author":"Q Sun","year":"2024","unstructured":"Sun Q, Bravo Iniguez A, Tian Q, Du M, Zhu M-J. Dietary cannabidiol activates PKA\/AMPK signaling and attenuates chronic inflammation and leaky gut in DSS-induced colitis mice. Mol Nutr Food Res. 2024;68:e2300446.","journal-title":"Mol Nutr Food Res"},{"key":"3733_CR7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/biom10111575","volume":"10","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders. Biomolecules. 2020;10:1575.","journal-title":"Biomolecules"},{"key":"3733_CR8","volume":"14","author":"M Schouten","year":"2023","unstructured":"Schouten M, Dalle S, Mantini D, Koppo K. Cannabidiol and brain function: current knowledge and future perspectives. Front Pharmacol. 2023;14:1328885.","journal-title":"Front Pharmacol"},{"key":"3733_CR9","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/molecules28073271","volume":"28","author":"J Castillo-Arellano","year":"2023","unstructured":"Castillo-Arellano J, Canseco-Alba A, Cutler SJ, Le\u00f3n F. The polypharmacological effects of cannabidiol. Molecules. 2023;28:3271.","journal-title":"Molecules"},{"key":"3733_CR10","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules28165980","volume":"28","author":"N Martinez Naya","year":"2023","unstructured":"Martinez Naya N, Kelly J, Corna G, Golino M, Abbate A, Toldo S. Molecular and cellular mechanisms of action of cannabidiol. Molecules. 2023;28:5980.","journal-title":"Molecules"},{"key":"3733_CR11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.866052","volume":"13","author":"A Morcuende","year":"2022","unstructured":"Morcuende A, Garc\u00eda-Guti\u00e9rrez MS, Tambaro S, Nieto E, Manzanares J, Femenia T. Immunomodulatory role of CB2 receptors in emotional and cognitive disorders. Front Psychiatry. 2022;13:866052.","journal-title":"Front Psychiatry"},{"key":"3733_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","volume":"130","author":"J Peng","year":"2022","unstructured":"Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol. 2022;130:439\u201356.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3733_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.","journal-title":"Syst Rev"},{"key":"3733_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"3733_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"key":"3733_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"3733_CR17","unstructured":"L\u00fcdecke D. esc: Effect Size Computation for Meta Analysis. R package version 0.5.1. 2019. https:\/\/CRAN.R-project.org\/package=esc. Accessed October 20, 2025."},{"key":"3733_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153\u201360.","journal-title":"Evid Based Ment Health"},{"key":"3733_CR19","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert DD. dmetar: Companion R Package For The Guide \u2018Doing Meta-Analysis in R\u2019. R package version 0.1.0. 2019. http:\/\/dmetar.protectlab.org\/. Accessed October 20, 2025."},{"key":"3733_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the meta for Package. J Stat Softw. 2010;36:1\u201348.","journal-title":"J Stat Softw"},{"key":"3733_CR21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"3733_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1:112\u201325.","journal-title":"Res Synth Methods"},{"key":"3733_CR23","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cells13191618","volume":"13","author":"K Brown","year":"2024","unstructured":"Brown K, Funk K, Figueroa Barrientos A, Bailey A, Shrader S, Feng W, et al. The modulatory effects and therapeutic potential of cannabidiol in the gut. Cells. 2024;13:1618.","journal-title":"Cells"},{"key":"3733_CR24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41386-024-02005-y","volume":"50","author":"RC Gom","year":"2025","unstructured":"Gom RC, Wickramarachchi P, George AG, Lightfoot SHM, Newton-Gunderson D, Hill MN, et al. Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats. Neuropsychopharmacology. 2025;50:751\u201361.","journal-title":"Neuropsychopharmacology"},{"key":"3733_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.23958\/ijirms\/vol07-i06\/1418","volume":"7","author":"Y-S Ding","year":"2022","unstructured":"Ding Y-S, Wang J, Kumar V, Ciaccio J, Dakhel S, Tan C, et al. Evidence for cannabidiol modulation of serotonergic transmission in a model of osteoarthritis via in vivo PET imaging and behavioral assessment. Int J Innov Res Med Sci. 2022;7:254\u201371.","journal-title":"Int J Innov Res Med Sci"},{"key":"3733_CR26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.931384","volume":"13","author":"R Chesworth","year":"2022","unstructured":"Chesworth R, Cheng D, Staub C, Karl T. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model. Front Pharmacol. 2022;13:931384.","journal-title":"Front Pharmacol"},{"key":"3733_CR27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/biom12101462","volume":"12","author":"J Matheson","year":"2022","unstructured":"Matheson J, Bourgault Z, Le Foll B. Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: A scoping review. Biomolecules. 2022;12:1462.","journal-title":"Biomolecules"},{"key":"3733_CR28","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/nu14102101","volume":"14","author":"RB Child","year":"2022","unstructured":"Child RB, Tallon MJ. Cannabidiol (CBD) dosing: Plasma pharmacokinetics and effects on accumulation in skeletal muscle, liver and adipose tissue. Nutrients. 2022;14:2101.","journal-title":"Nutrients"},{"key":"3733_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-1119(02)00598-X","volume":"291","author":"NS Waleh","year":"2002","unstructured":"Waleh NS, Cravatt BF, Apte-Deshpande A, Terao A, Kilduff TS. Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene. 2002;291:203\u201310.","journal-title":"Gene"},{"key":"3733_CR30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/09513590410001692492","volume":"18","author":"N Lazzarin","year":"2004","unstructured":"Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agr\u00f2 A, et al. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol. 2004;18:212\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"3733_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41583-021-00513-0","volume":"22","author":"DA Bangasser","year":"2021","unstructured":"Bangasser DA, Cuarenta A. Sex differences in anxiety and depression: circuits and mechanisms. Nat Rev Neurosci. 2021;22:674\u201384.","journal-title":"Nat Rev Neurosci"},{"key":"3733_CR32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jne.12179","volume":"26","author":"D Toufexis","year":"2014","unstructured":"Toufexis D, Rivarola MA, Lara H, Viau V. Stress and the reproductive axis. J Neuroendocrinol. 2014;26:573\u201386.","journal-title":"J Neuroendocrinol"},{"key":"3733_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","volume":"160","author":"D De Gregorio","year":"2019","unstructured":"De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. 2019;160:136\u201350.","journal-title":"Pain"},{"key":"3733_CR34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","volume":"156","author":"LBM Resstel","year":"2009","unstructured":"Resstel LBM, Tavares RF, Lisboa SFS, Joca SRL, Corr\u00eaa FMA, Guimar\u00e3es FS. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol. 2009;156:181\u20138.","journal-title":"Br J Pharmacol"},{"key":"3733_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","volume":"199","author":"AC Campos","year":"2008","unstructured":"Campos AC, Guimar\u00e3es FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008;199:223\u201330.","journal-title":"Psychopharmacology (Berl)"},{"key":"3733_CR36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","volume":"24","author":"MV Foga\u00e7a","year":"2014","unstructured":"Foga\u00e7a MV, Reis FMCV, Campos AC, Guimar\u00e3es FS. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropsychopharmacol. 2014;24:410\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3733_CR37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/ph15040473","volume":"15","author":"A Austrich-Olivares","year":"2022","unstructured":"Austrich-Olivares A, Garc\u00eda-Guti\u00e9rrez MS, Illescas L, Gasparyan A, Manzanares J. Cannabinoid CB1 receptor involvement in the actions of CBD on anxiety and coping behaviors in mice. Pharmaceuticals (Basel). 2022;15:473.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3733_CR38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.694510","volume":"12","author":"A Gasparyan","year":"2021","unstructured":"Gasparyan A, Navarrete F, Manzanares J. Cannabidiol and sertraline regulate behavioral and brain gene expression alterations in an animal model of PTSD. Front Pharmacol. 2021;12:694510.","journal-title":"Front Pharmacol"},{"key":"3733_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11011-020-00667-3","volume":"36","author":"YC Chaves","year":"2021","unstructured":"Chaves YC, Genaro K, Crippa JA, da Cunha JM, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action. Metab Brain Dis. 2021;36:639\u201352.","journal-title":"Metab Brain Dis"},{"key":"3733_CR40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1358555","volume":"18","author":"BJ Yadav-Samudrala","year":"2024","unstructured":"Yadav-Samudrala BJ, Gorman BL, Barmada KM, Ravula HP, Huguely CJ, Wallace ED, et al. Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice. Front Neurosci. 2024;18:1358555.","journal-title":"Front Neurosci"},{"key":"3733_CR41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","volume":"135","author":"MV Foga\u00e7a","year":"2018","unstructured":"Foga\u00e7a MV, Campos AC, Coelho LD, Duman RS, Guimar\u00e3es FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. Neuropharmacology. 2018;135:22\u201333.","journal-title":"Neuropharmacology"},{"key":"3733_CR42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/brainsci14100999","volume":"14","author":"B Poudel","year":"2024","unstructured":"Poudel B, Bany BM, Hales DB, Cheatwood JL. Effects of cannabidiol (CBD) on Doxorubicin-induced anxiety and depression-like behaviors and mRNA expression of inflammatory markers in rats. Brain Sci. 2024;14:999.","journal-title":"Brain Sci"},{"key":"3733_CR43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2024.04.010","volume":"119","author":"F da Silva Rodrigues","year":"2024","unstructured":"da Silva Rodrigues F, Jantsch J, de Farias Fraga G, Luiza de Camargo Milczarski V, Silva Dias V, Scheid C, et al. Cannabidiol improves maternal obesity-induced behavioral, neuroinflammatory and neurochemical dysfunctions in the juvenile offspring. Brain Behav Immun. 2024;119:301\u201316.","journal-title":"Brain Behav Immun"},{"key":"3733_CR44","volume":"262","author":"FdaS Rodrigues","year":"2025","unstructured":"Rodrigues FdaS, Jantsch J, de Farias Fraga G, Dias VS, Pereira Medeiros C, Wickert F, et al. Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring. Neuropharmacology. 2025;262:110196.","journal-title":"Neuropharmacology"},{"key":"3733_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135020","volume":"729","author":"YC Chaves","year":"2020","unstructured":"Chaves YC, Genaro K, Stern CA, de Oliveira Guaita G, de Souza Crippa JA, da Cunha JM, et al. Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Neurosci Lett. 2020;729:135020.","journal-title":"Neurosci Lett"},{"key":"3733_CR46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1171646","volume":"14","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2023","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Navarro D, Austrich-Olivares A, Manzanares J. Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model. Front Pharmacol. 2023;14:1171646.","journal-title":"Front Pharmacol"},{"key":"3733_CR47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2014.12.051","volume":"289","author":"AC Campos","year":"2015","unstructured":"Campos AC, Brant F, Miranda AS, Machado FS, Teixeira AL. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria. Neuroscience. 2015;289:166\u201380.","journal-title":"Neuroscience"},{"key":"3733_CR48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","volume":"75","author":"MA Mori","year":"2017","unstructured":"Mori MA, Meyer E, Soares LM, Milani H, Guimar\u00e3es FS, de Oliveira RMW. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Prog Neuropsychopharmacol Biol Psychiatry. 2017;75:94\u2013105.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3733_CR49","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1007\/s12035-021-02479-7","volume":"58","author":"E Meyer","year":"2021","unstructured":"Meyer E, Bonato JM, Mori MA, Mattos BA, Guimar\u00e3es FS, Milani H, et al. Cannabidiol confers neuroprotection in rats in a model of transient global cerebral ischemia: Impact of hippocampal synaptic neuroplasticity. Mol Neurobiol. 2021;58:5338\u201355.","journal-title":"Mol Neurobiol"},{"key":"3733_CR50","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/ejn.15134","volume":"53","author":"MA Mori","year":"2021","unstructured":"Mori MA, Meyer E, da Silva FF, Milani H, Guimar\u00e3es FS, Oliveira RMW. Differential contribution of CB1, CB2, 5-HT1A, and PPAR-\u03b3 receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments. Eur J Neurosci. 2021;53:1738\u201351.","journal-title":"Eur J Neurosci"},{"key":"3733_CR51","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.711639","volume":"15","author":"JS Kaplan","year":"2021","unstructured":"Kaplan JS, Wagner JK, Reid K, McGuinness F, Arvila S, Brooks M, et al. Cannabidiol exposure during the mouse adolescent period is without harmful behavioral effects on locomotor activity, anxiety, and spatial memory. Front Behav Neurosci. 2021;15:711639.","journal-title":"Front Behav Neurosci"},{"key":"3733_CR52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.891842","volume":"13","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2022","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Fuster MJ. Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats. Front Pharmacol. 2022;13:891842.","journal-title":"Front Pharmacol"},{"key":"3733_CR53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.brainresbull.2021.06.017","volume":"174","author":"RB Malvestio","year":"2021","unstructured":"Malvestio RB, Medeiros P, Negrini-Ferrari SE, Oliveira-Silva M, Medeiros AC, Padovan CM, et al. Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors. Brain Res Bull. 2021;174:323\u201338.","journal-title":"Brain Res Bull"},{"key":"3733_CR54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","volume":"103","author":"R Linge","year":"2016","unstructured":"Linge R, Jim\u00e9nez-S\u00e1nchez L, Campa L, Pilar-Cu\u00e9llar F, Vidal R, Pazos A, et al. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. 2016;103:16\u201326.","journal-title":"Neuropharmacology"},{"key":"3733_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pnpbp.2018.06.002","volume":"86","author":"AJ Sales","year":"2018","unstructured":"Sales AJ, Crestani CC, Guimar\u00e3es FS, Joca SRL. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:255\u201361.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3733_CR56","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijms24032052","volume":"24","author":"U Bright","year":"2023","unstructured":"Bright U, Akirav I. Cannabidiol modulates alterations in PFC microRNAs in a rat model of depression. Int J Mol Sci. 2023;24:2052.","journal-title":"Int J Mol Sci"},{"key":"3733_CR57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","volume":"303","author":"AG Sartim","year":"2016","unstructured":"Sartim AG, Guimar\u00e3es FS, Joca SRL. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors. Behav Brain Res. 2016;303:218\u201327.","journal-title":"Behav Brain Res"},{"key":"3733_CR58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","volume":"159","author":"TV Zanelati","year":"2010","unstructured":"Zanelati TV, Biojone C, Moreira FA, Guimar\u00e3es FS, Joca SRL. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors: Cannabidiol induces antidepressant-like effect. Br J Pharmacol. 2010;159:122\u20138.","journal-title":"Br J Pharmacol"},{"key":"3733_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135594","volume":"744","author":"MA Abame","year":"2021","unstructured":"Abame MA, He Y, Wu S, Xie Z, Zhang J, Gong X, et al. Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus. Neurosci Lett. 2021;744:135594.","journal-title":"Neurosci Lett"},{"key":"3733_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114433","volume":"185","author":"E Florensa-Zanuy","year":"2021","unstructured":"Florensa-Zanuy E, Garro-Mart\u00ednez E, Adell A, Castro E, D\u00edaz \u00c1, Pazos \u00c1, et al. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways. Biochem Pharmacol. 2021;185:114433.","journal-title":"Biochem Pharmacol"},{"key":"3733_CR61","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s43440-021-00301-8","volume":"73","author":"PAL Tito","year":"2021","unstructured":"Tito PAL, Bernardino TC, de S, Bellozi PMQ, da Silva MCM, de Miranda AS, Vieira \u00c9LM, et al. Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain. Pharmacol Rep. 2021;73:1680\u201393.","journal-title":"Pharmacol Rep"},{"key":"3733_CR62","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/0269881118784877","volume":"32","author":"AG Sartim","year":"2018","unstructured":"Sartim AG, Sales AJ, Guimar\u00e3es FS, Joca SR. Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test. J Psychopharmacol. 2018;32:922\u201331.","journal-title":"J Psychopharmacol"},{"key":"3733_CR63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","volume":"23","author":"GZ R\u00e9us","year":"2011","unstructured":"R\u00e9us GZ, Stringari RB, Ribeiro KF, Luft T, Abelaira HM, Fries GR, et al. Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala. Acta Neuropsychiatr. 2011;23:241\u20138.","journal-title":"Acta Neuropsychiatr"},{"key":"3733_CR64","volume":"70","author":"C Xu","year":"2019","unstructured":"Xu C, Chang T, Du Y, Yu C, Tan X, Li X. Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model. Environ Toxicol Pharmacol. 2019;70:103202.","journal-title":"Environ Toxicol Pharmacol"},{"key":"3733_CR65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109870","volume":"248","author":"LB Domingos","year":"2024","unstructured":"Domingos LB, M\u00fcller HK, da Silva NR, Filiou MD, Nielsen AL, Guimar\u00e3es FS, et al. Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression. Neuropharmacology. 2024;248:109870.","journal-title":"Neuropharmacology"},{"key":"3733_CR66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112627","volume":"388","author":"AJ Sales","year":"2020","unstructured":"Sales AJ, Guimar\u00e3es FS, Joca SRL. CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim. Behav Brain Res. 2020;388:112627.","journal-title":"Behav Brain Res"},{"key":"3733_CR67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11684-021-0896-8","volume":"16","author":"M Hou","year":"2022","unstructured":"Hou M, Wang S, Yu D, Lu X, Zhao X, Chen Z, et al. Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation. Front Med. 2022;16:227\u201339.","journal-title":"Front Med"},{"key":"3733_CR68","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110153","volume":"261","author":"Z Shen","year":"2024","unstructured":"Shen Z, Bao N, Chen J, Tang M, Yang L, Yang Y, et al. Neuromolecular and behavioral effects of cannabidiol on depressive-associated behaviors and neuropathic pain conditions in mice. Neuropharmacology. 2024;261:110153.","journal-title":"Neuropharmacology"},{"key":"3733_CR69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2018.06.006","volume":"682","author":"H de Morais","year":"2018","unstructured":"de Morais H, Chaves YC, Waltrick APF, Jesus CHA, Genaro K, Crippa JA, et al. Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats. Neurosci Lett. 2018;682:62\u20138.","journal-title":"Neurosci Lett"},{"key":"3733_CR70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.30.051606.094328","volume":"30","author":"H Eichenbaum","year":"2007","unstructured":"Eichenbaum H, Yonelinas AP, Ranganath C. The medial temporal lobe and recognition memory. Annu Rev Neurosci. 2007;30:123\u201352.","journal-title":"Annu Rev Neurosci"},{"key":"3733_CR71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","volume":"159","author":"I Magen","year":"2010","unstructured":"Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation: Cannabidiol improves cognition in cholestasis. Br J Pharmacol. 2010;159:950\u20137.","journal-title":"Br J Pharmacol"},{"key":"3733_CR72","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3390\/biomedicines10081811","volume":"10","author":"Z G\u00e1ll","year":"2022","unstructured":"G\u00e1ll Z, Kelemen K, Tolok\u00e1n A, Zolcseak I, S\u00e1vel I, Bod R, et al. Anticonvulsant action and long-term effects of chronic cannabidiol treatment in the rat pentylenetetrazole-kindling model of epilepsy. Biomedicines. 2022;10:1811.","journal-title":"Biomedicines"},{"key":"3733_CR73","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12778","volume":"25","author":"M\u00c1 Luj\u00e1n","year":"2020","unstructured":"Luj\u00e1n M\u00c1, Cantacorps L, Valverde O. The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake. Addict Biol. 2020;25:e12778.","journal-title":"Addict Biol"},{"key":"3733_CR74","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11064-023-04041-4","volume":"49","author":"H Aghamiri","year":"2024","unstructured":"Aghamiri H, Jafari-Sabet M, Hoormand M. Ameliorative effect of cannabidiol on topiramate-induced memory loss: The role of hippocampal and prefrontal cortical NMDA receptors and CREB\/BDNF signaling pathways in rats. Neurochem Res. 2024;49:363\u201378.","journal-title":"Neurochem Res"},{"key":"3733_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","volume":"26","author":"AP Schiavon","year":"2014","unstructured":"Schiavon AP, Soares LM, Bonato JM, Milani H, Guimar\u00e3es FS, Weffort de Oliveira RM. Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox Res. 2014;26:307\u201316.","journal-title":"Neurotox Res"},{"key":"3733_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111813","volume":"141","author":"A Garc\u00eda-Baos","year":"2021","unstructured":"Garc\u00eda-Baos A, Puig-Reyne X, Garc\u00eda-Algar \u00d3, Valverde O. Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model. Biomed Pharmacother. 2021;141:111813.","journal-title":"Biomed Pharmacother"},{"key":"3733_CR77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3897\/folmed.65.e107259","volume":"65","author":"M Georgieva-Kotetarova","year":"2023","unstructured":"Georgieva-Kotetarova M, Kandilarov I, Vilmosh N, Zlatanova H, Yanchev N, Delev D, et al. Cannabidiol improves memory and decreases IL-1\u03b2 serum levels in rats with lipopolysaccharide-induced inflammation. Folia Med (Plovdiv). 2023;65:940\u20139.","journal-title":"Folia Med (Plovdiv)"},{"key":"3733_CR78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","volume":"164","author":"FV Gomes","year":"2015","unstructured":"Gomes FV, Llorente R, Del Bel EA, Viveros M-P, L\u00f3pez-Gallardo M, Guimar\u00e3es FS. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Schizophr Res. 2015;164:155\u201363.","journal-title":"Schizophr Res"},{"key":"3733_CR79","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","volume":"63","author":"MR Pazos","year":"2012","unstructured":"Pazos MR, Cinquina V, G\u00f3mez A, Layunta R, Santos M, Fern\u00e1ndez-Ruiz J, et al. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 2012;63:776\u201383.","journal-title":"Neuropharmacology"},{"key":"3733_CR80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","volume":"1348","author":"OJ Cassol-Jr","year":"2010","unstructured":"Cassol-Jr OJ, Comim CM, Silva BR, Hermani FV, Constantino LS, Felisberto F, et al. Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Res. 2010;1348:128\u201338.","journal-title":"Brain Res"},{"key":"3733_CR81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbi.2022.06.003","volume":"104","author":"M Li","year":"2022","unstructured":"Li M, Xu B, Li X, Li Y, Qiu S, Chen K, et al. Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models. Brain Behav Immun. 2022;104:155\u201370.","journal-title":"Brain Behav Immun"},{"key":"3733_CR82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/can.2022.0011","volume":"8","author":"CD Drummond-Main","year":"2023","unstructured":"Drummond-Main CD, Ahn Y, Kesler M, Gavrilovici C, Kim DY, Kiroski I, et al. Cannabidiol impairs brain mitochondrial metabolism and neuronal integrity. Cannabis Cannabinoid Res. 2023;8:283\u201398.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3733_CR83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-191242","volume":"74","author":"G Watt","year":"2020","unstructured":"Watt G, Shang K, Zieba J, Olaya J, Li H, Garner B, et al. Chronic treatment with 50 mg\/kg cannabidiol improves cognition and moderately reduces A\u03b240 levels in 12-month-old male A\u03b2PPswe\/PS1\u0394E9 transgenic mice. J Alzheimers Dis. 2020;74:937\u201350.","journal-title":"J Alzheimers Dis"},{"key":"3733_CR84","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587604","volume":"11","author":"M Coles","year":"2020","unstructured":"Coles M, Watt G, Kreilaus F, Karl T. Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APP Swe \/PS1\u0394E9 transgenic female mice. Front Pharmacol. 2020;11:587604.","journal-title":"Front Pharmacol"},{"key":"3733_CR85","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/s41380-024-02789-x","volume":"30","author":"J Jin","year":"2025","unstructured":"Jin J, Fu C, Xia J, Luo H, Wang X, Chen S, et al. Cannabidiol ameliorates cognitive decline in 5\u00d7FAD mouse model of Alzheimer\u2019s disease through potentiating the function of extrasynaptic glycine receptors. Mol Psychiatry. 2025;30:1817\u201327.","journal-title":"Mol Psychiatry"},{"key":"3733_CR86","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000519534","volume":"81","author":"M Amini","year":"2022","unstructured":"Amini M, Abdolmaleki Z. The effect of cannabidiol coated by nano-chitosan on learning and memory, hippocampal CB1 and CB2 levels, and amyloid plaques in an Alzheimer\u2019s disease rat model. Neuropsychobiology. 2022;81:171\u201383.","journal-title":"Neuropsychobiology"},{"key":"3733_CR87","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","volume":"42","author":"D Cheng","year":"2014","unstructured":"Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice. J Alzheimers Dis. 2014;42:1383\u201396.","journal-title":"J Alzheimers Dis"},{"key":"3733_CR88","doi-asserted-by":"crossref","unstructured":"Alvarez FJ, Alvarez AA, Rodr\u00edguez JJ, Lafuente H, Canduela MJ, Hind W, et al. Effects of cannabidiol, hypothermia, and their combination in newborn rats with hypoxic-ischemic encephalopathy. eNeuro. 2023;10:0417\u201322.","DOI":"10.1523\/ENEURO.0417-22.2023"},{"key":"3733_CR89","doi-asserted-by":"crossref","first-page":"e2009","DOI":"10.1089\/neu.2023.0539","volume":"41","author":"S Dong","year":"2024","unstructured":"Dong S, Zhao H, Nie M, Sha Z, Feng J, Liu M, et al. Cannabidiol alleviates neurological deficits after traumatic brain injury by improving intracranial lymphatic drainage. J Neurotrauma. 2024;41:e2009\u2013e2025.","journal-title":"J Neurotrauma"},{"key":"3733_CR90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","volume":"498","author":"L Wang","year":"2022","unstructured":"Wang L, Wu X, Yang G, Hu N, Zhao Z, Zhao L, et al. Cannabidiol alleviates the damage to dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease mice via regulating neuronal apoptosis and neuroinflammation. Neuroscience. 2022;498:64\u201372.","journal-title":"Neuroscience"},{"key":"3733_CR91","first-page":"61","volume":"11","author":"M Kodali","year":"2024","unstructured":"Kodali M, Madhu LN, Kolla VSV, Attaluri S, Huard C, Somayaji Y, et al. FDA-approved cannabidiol [Epidiolex\u00ae] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis. Mil Med Res. 2024;11:61.","journal-title":"Mil Med Res"},{"key":"3733_CR92","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148771","volume":"1828","author":"F Frederico Gava","year":"2024","unstructured":"Frederico Gava F, Jaconi De Carli R, Stork S, Gainski Danielski L, Bonfante S, Joaquim L, et al. Cannabidiol effect on long-term brain alterations in septic rats: Involvement of PPAR\u03b3 activation. Brain Res. 2024;1828:148771.","journal-title":"Brain Res"},{"key":"3733_CR93","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110367","volume":"111","author":"AB Sonego","year":"2021","unstructured":"Sonego AB, Prado DdaS, Guimar\u00e3es FS. PPAR\u03b3 receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110367.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3733_CR94","volume":"417","author":"MDS Corr\u00ea","year":"2022","unstructured":"Corr\u00ea MDS, de Freitas BS, Machado GDB, Pires VN, Bromberg E, Hallak JEC, et al. Cannabidiol reverses memory impairments and activates components of the Akt\/GSK3\u03b2 pathway in an experimental model of estrogen depletion. Behav Brain Res. 2022;417:113555.","journal-title":"Behav Brain Res"},{"key":"3733_CR95","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/ijms23031076","volume":"23","author":"D de Paula Faria","year":"2022","unstructured":"de Paula Faria D, Estessi de Souza L, Duran FL, de S, Buchpiguel CA, Britto LR, Crippa JA, de S, et al. Cannabidiol treatment improves glucose metabolism and memory in streptozotocin-induced Alzheimer\u2019s disease rat model: A proof-of-concept study. Int J Mol Sci. 2022;23:1076.","journal-title":"Int J Mol Sci"},{"key":"3733_CR96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s42238-020-00055-9","volume":"2","author":"ZT Montoya","year":"2020","unstructured":"Montoya ZT, Uhernik AL, Smith JP. Comparison of cannabidiol to citalopram in targeting fear memory in female mice. J Cannabis Res. 2020;2:48.","journal-title":"J Cannabis Res"},{"key":"3733_CR97","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/bph.14895","volume":"177","author":"AM Raymundi","year":"2020","unstructured":"Raymundi AM, da Silva TR, Zampronio AR, Guimar\u00e3es FS, Bertoglio LJ, Stern CAJA. time-dependent contribution of hippocampal CB1, CB2 and PPAR\u03b3 receptors to cannabidiol-induced disruption of fear memory consolidation. Br J Pharmacol. 2020;177:945\u201357.","journal-title":"Br J Pharmacol"},{"key":"3733_CR98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1017\/neu.2023.13","volume":"36","author":"YC Chaves","year":"2024","unstructured":"Chaves YC, Raymundi AM, Waltrick APF, de Souza Crippa JA, Stern CAJ, da Cunha JM, et al. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatr. 2024;36:276\u201386.","journal-title":"Acta Neuropsychiatr"},{"key":"3733_CR99","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","volume":"26","author":"FV Gomes","year":"2012","unstructured":"Gomes FV, Reis DG, Alves FHF, Corr\u00eaa FMA, Guimar\u00e3es FS, Resstel LBM. Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol. 2012;26:104\u201313.","journal-title":"J Psychopharmacol"},{"key":"3733_CR100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","volume":"18","author":"RM Bitencourt","year":"2008","unstructured":"Bitencourt RM, Pamplona FA, Takahashi RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008;18:849\u201359.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3733_CR101","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41386-018-0282-7","volume":"44","author":"HJ Szkudlarek","year":"2019","unstructured":"Szkudlarek HJ, Desai SJ, Renard J, Pereira B, Norris C, Jobson CEL, et al. \u0394-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors. Neuropsychopharmacology. 2019;44:817\u201325.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03733-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:58:00Z","timestamp":1792011480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03733-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3733"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03733-x","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}